RÉSUMÉ
The endoplasmic reticulum (ER) is an essential organelle that maintains intracellular Ca2+ homeostasis, folds newly synthesized secreted and membrane proteins, and facilitates post-translational protein modifications. Misfolding and aggregation of unfolded proteins within the ER lumen can activate endoplasmic reticulum stress (ERS), which in turn activates three different downstream signaling pathways: protein kinase R-like endoplasmic reticulum kinase (PERK), inositol-requiring enzyme 1α(IRE-1α), and activating transcription factor 6 (ATF6). These pathways affect cell survival, differentiation, and phenotype transition. Recent studies have shown a close interaction between the downstream signaling cascade of ERS and the signaling pathways that induce macrophage polarization towards pro-inflammatory M1 type (IFN-γ and LPS) and anti-inflammatory M2 type (IL-4 and IL-10). However, the specific molecular mechanisms underlying these interactions are complex and intriate. The article summarizes the primary mechanisms by which ERS mediates macrophage polarization, focusing on discussing the molecular mechanisms by which three different downstream signals of ERS affect macrophage polarization.
Sujet(s)
Stress du réticulum endoplasmique , Macrophages , Transduction du signal , Macrophages/métabolisme , Humains , Animaux , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Protein-Serine-Threonine Kinases/métabolisme , Protein-Serine-Threonine Kinases/physiologie , Activation des macrophages , eIF-2 Kinase/métabolisme , Réticulum endoplasmique/métabolisme , Polarité de la celluleRÉSUMÉ
Activating transcription factor 6 (ATF6) is one of three endoplasmic reticulum (ER) transmembrane stress sensors that mediate the unfolded protein response (UPR). Despite its crucial role in long-term ER stress adaptation, regulation of ATF6 alpha (α) signalling remains poorly understood, possibly because its activation involves ER-to-Golgi and nuclear trafficking. Here, we generated an ATF6α/Inositol-requiring kinase 1 (IRE1) dual UPR reporter CHO-K1 cell line and performed an unbiased genome-wide CRISPR/Cas9 mutagenesis screen to systematically profile genetic factors that specifically contribute to ATF6α signalling in the presence and absence of ER stress. The screen identified both anticipated and new candidate genes that regulate ATF6α activation. Among these, calreticulin (CRT), a key ER luminal chaperone, selectively repressed ATF6α signalling: Cells lacking CRT constitutively activated a BiP::sfGFP ATF6α-dependent reporter, had higher BiP levels and an increased rate of trafficking and processing of ATF6α. Purified CRT interacted with the luminal domain of ATF6α in vitro and the two proteins co-immunoprecipitated from cell lysates. CRT depletion exposed a negative feedback loop implicating ATF6α in repressing IRE1 activity basally and overexpression of CRT reversed this repression. Our findings indicate that CRT, beyond its known role as a chaperone, also serves as an ER repressor of ATF6α to selectively regulate one arm of the UPR.
Sujet(s)
Facteur de transcription ATF-6 , Systèmes CRISPR-Cas , Calréticuline , Cricetulus , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Calréticuline/métabolisme , Calréticuline/génétique , Animaux , Cellules CHO , Humains , Réponse aux protéines mal repliées , Stress du réticulum endoplasmique/génétique , Protein-Serine-Threonine Kinases/métabolisme , Protein-Serine-Threonine Kinases/génétique , Transduction du signalRÉSUMÉ
The pathogenesis of non-alcoholic fatty liver disease (NAFLD) is influenced by a number of variables, including endoplasmic reticulum stress (ER). Thioredoxin domain-containing 5 (TXNDC5) is a member of the protein disulfide isomerase family and acts as an endoplasmic reticulum (ER) chaperone. Nevertheless, the function of TXNDC5 in hepatocytes under ER stress remains largely uncharacterized. In order to identify the role of TXNDC5 in hepatic wild-type (WT) and TXNDC5-deficient (KO) AML12 cell lines, tunicamycin, palmitic acid, and thapsigargin were employed as stressors. Cell viability, mRNA, protein levels, and mRNA splicing were then assayed. The protein expression results of prominent ER stress markers indicated that the ERN1 and EIF2AK3 proteins were downregulated, while the HSPA5 protein was upregulated. Furthermore, the ATF6 protein demonstrated no significant alterations in the absence of TXNDC5 at the protein level. The knockout of TXNDC5 has been demonstrated to increase cellular ROS production and its activity is required to maintain normal mitochondrial function during tunicamycin-induced ER stress. Tunicamycin has been observed to disrupt the protein levels of HSPA5, ERN1, and EIF2AK3 in TXNDC5-deficient cells. However, palmitic acid has been observed to disrupt the protein levels of ATF6, HSPA5, and EIF2AK3. In conclusion, TXNDC5 can selectively activate distinct ER stress pathways via HSPA5, contingent on the origin of ER stress. Conversely, the absence of TXNDC5 can disrupt the EIF2AK3 cascade.
Sujet(s)
Chaperonne BiP du réticulum endoplasmique , Stress du réticulum endoplasmique , Réticulum endoplasmique , Hépatocytes , Protein Disulfide-Isomerases , Transduction du signal , Tunicamycine , Chaperonne BiP du réticulum endoplasmique/métabolisme , Protein Disulfide-Isomerases/métabolisme , Protein Disulfide-Isomerases/génétique , Hépatocytes/métabolisme , Animaux , Tunicamycine/pharmacologie , Réticulum endoplasmique/métabolisme , Souris , Espèces réactives de l'oxygène/métabolisme , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Lignée cellulaire , Protein-Serine-Threonine Kinases/métabolisme , Protein-Serine-Threonine Kinases/génétique , Protéines du choc thermique/métabolisme , Protéines du choc thermique/génétique , Endoribonucleases/métabolisme , Endoribonucleases/génétique , Acide palmitique/pharmacologie , Acide palmitique/métabolisme , Thapsigargine/pharmacologie , Humains , Stéatose hépatique non alcoolique/métabolisme , Stéatose hépatique non alcoolique/génétique , Stéatose hépatique non alcoolique/anatomopathologie , Thiorédoxines/métabolisme , Thiorédoxines/génétique , Survie cellulaire/effets des médicaments et des substances chimiquesRÉSUMÉ
Head and neck squamous carcinoma (HNSC) is a prevalent malignant disease, with the majority of patients being diagnosed at an advanced stage. Endoplasmic reticulum stress (ERS) is considered to be a process that promotes tumorigenesis and impacts the tumor microenvironment (TME) in various cancers. The study aims to investigate the predictive value of ERS in HNSC and explore the correlation between ERS-related genes and TME. A series of bioinformatics analyses were carried out based on mRNA and scRNA-seq data from the TCGA and GEO databases. We conducted RT-qPCR and western blot to validate the signature, and performed cell functional experiments to investigate the in vitro biological functions of the gene. We identified 63 ERS-related genes that were associated with outcome and stage in HNSC. A three-gene signature (ATF6, TRIB3, and UBXN6) was developed, which presents predictive value in the prognosis and immunotherapy response of HNSC patients. The high-risk group exhibited a worse prognosis but may benefit from immunotherapy. Furthermore, there was a significant correlation between the signature and immune infiltration. In the high-risk group, fibroblasts were more active in intercellular communication, and more T cells were observed at the end of the sequential phase. The genes in the ERS-related signature were overexpressed in HNSC cells, and the knockdown of TRIB3 significantly inhibited cell proliferation and migration. This study established a novel ERS-related signature that has potential implications for HNSC therapy and the understanding of TME.
Sujet(s)
Stress du réticulum endoplasmique , Régulation de l'expression des gènes tumoraux , Tumeurs de la tête et du cou , Carcinome épidermoïde de la tête et du cou , Microenvironnement tumoral , Humains , Stress du réticulum endoplasmique/génétique , Carcinome épidermoïde de la tête et du cou/génétique , Carcinome épidermoïde de la tête et du cou/anatomopathologie , Tumeurs de la tête et du cou/génétique , Tumeurs de la tête et du cou/anatomopathologie , Tumeurs de la tête et du cou/métabolisme , Microenvironnement tumoral/génétique , Pronostic , Lignée cellulaire tumorale , Protein-Serine-Threonine Kinases/génétique , Protein-Serine-Threonine Kinases/métabolisme , Protein-Serine-Threonine Kinases/antagonistes et inhibiteurs , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Femelle , Prolifération cellulaire/génétique , Biologie informatique/méthodes , Marqueurs biologiques tumoraux/génétique , Marqueurs biologiques tumoraux/métabolisme , Mâle , Mouvement cellulaire/génétique , Analyse de profil d'expression de gènes , Transcriptome , Protéines de répression , Protéines du cycle cellulaireRÉSUMÉ
Circular RNAs (circRNAs) are covalently closed, single-stranded RNAs that play critical roles in various biological processes and diseases, including cancers. However, the functions and mechanisms of circRNAs in hepatocellular carcinoma (HCC) need further clarification. Here, we identified and confirmed that circATF6 is downregulated in HCC tissues and negatively associated with the overall survival of HCC patients. Ectopic overexpression of circATF6 inhibits malignant phenotypes of HCC cells in vitro and in vivo, while knockdown of circATF6 had opposite effects. Mechanistically, we found that circATF6 bound to calreticulin (CALR) protein and acted as a scaffold to enhance the interaction of CALR with calpain2 (CAPN2), which promoted the degradation of CALR by its enzymatic activity. Moreover, we found that circATF6 inhibited HCC cells by suppressing CALR-mediated wnt/ß-catenin signaling pathway. Taken together, our findings suggest that circATF6 is a potential prognostic biomarker and therapeutic target for HCC.
Sujet(s)
Calréticuline , Carcinome hépatocellulaire , Tumeurs du foie , ARN circulaire , Voie de signalisation Wnt , Animaux , Humains , Mâle , Souris , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , bêta-Caténine/métabolisme , Calpain/métabolisme , Calpain/génétique , Calréticuline/métabolisme , Calréticuline/génétique , Carcinome hépatocellulaire/anatomopathologie , Carcinome hépatocellulaire/génétique , Carcinome hépatocellulaire/métabolisme , Lignée cellulaire tumorale , Prolifération cellulaire , Évolution de la maladie , Régulation de l'expression des gènes tumoraux , Tumeurs du foie/anatomopathologie , Tumeurs du foie/génétique , Tumeurs du foie/métabolisme , Souris de lignée BALB C , Souris nude , ARN circulaire/génétique , ARN circulaire/métabolismeRÉSUMÉ
Cadmium (Cd) is a well-recognized male reproductive toxicant that can cause testicular germ cell apoptosis. However, the underlying mechanism needs investigation. CG-1 mouse spermatogonia (spg) cells were treated with 20⯵M cadmium chloride (CdCl2) for 24â¯h. Cell apoptosis was measured, and the expressions of key genes and protein biomarkers involved in endoplasmic reticulum (ER) stress were detected, respectively. Untargeted metabolomics was performed to identify different metabolites, and transcriptome analysis was conducted to screen differentially expressed genes (DEGs). Our results indicated that CdCl2 exposure caused cell apoptosis, and DEGs were involved in several apoptosis-related pathways. Moreover, CdCl2 exposure apparently increased the mRNA and protein expressions levels of both GRP78 and ATF6α, disrupting the expression of various metabolites, particularly amino acids. Conclusively, our study reveals the pathway of CdCl2 toxicity on mouse spg, providing a deep understanding of CdCl2-induced testicular toxicity.
Sujet(s)
Apoptose , Chlorure de cadmium , Chaperonne BiP du réticulum endoplasmique , Stress du réticulum endoplasmique , Spermatogonies , Transcriptome , Animaux , Mâle , Souris , Apoptose/effets des médicaments et des substances chimiques , Spermatogonies/effets des médicaments et des substances chimiques , Spermatogonies/métabolisme , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Transcriptome/effets des médicaments et des substances chimiques , Chlorure de cadmium/toxicité , Métabolomique , Lignée cellulaire , Facteur de transcription ATF-6/génétique , Facteur de transcription ATF-6/métabolisme , Cadmium/toxicitéRÉSUMÉ
Dihydropyrazines (DHPs) are formed by non-enzymatic glycation reactions in vivo and in food. We recently reported that 3-hydro-2,2,5,6-tetramethylpyrazine (DHP-3), which is a methyl-substituted DHP, caused severe oxidative stress and cytotoxicity. However, the molecular mechanisms underlying the cytotoxic pathways of the DHP response remain elusive. Because oxidative stress induces endoplasmic reticulum (ER) stress and autophagy, we investigated the ability of DHP-3 to modulate the ER stress and autophagy pathways. DHP-3 activated the ER stress pathway by increasing inositol-requiring enzyme 1 (IRE1) and PKR-like ER kinase (PERK) phosphorylation and transcription factor 6 (ATF6) expression. Moreover, DHP-3 increased the expression of activating transcription factor 4 (ATF4) and C/EBP homologous protein (CHOP), which are downstream targets of PERK. In addition, DHP-3 inhibited the autophagy pathway by increasing the accumulation of microtubule-associated protein 1 light chain 3 alpha-phosphatidylethanolamine conjugate (LC3-II) and p62/sequestosome 1 (p62), while decreasing autophagic flux. Taken together, these results indicate that DHP-3 activates the ER stress pathway and inhibits the autophagy pathway, suggesting that the resulting removal of damaged organelles is inadequate.
Sujet(s)
Facteur de transcription ATF-4 , Facteur de transcription ATF-6 , Autophagie , Stress du réticulum endoplasmique , Protein-Serine-Threonine Kinases , Pyrazines , eIF-2 Kinase , Humains , Autophagie/effets des médicaments et des substances chimiques , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Pyrazines/pharmacologie , Cellules HepG2 , Facteur de transcription ATF-4/métabolisme , Facteur de transcription ATF-4/génétique , eIF-2 Kinase/métabolisme , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Protein-Serine-Threonine Kinases/métabolisme , Protein-Serine-Threonine Kinases/génétique , Facteur de transcription CHOP/métabolisme , Facteur de transcription CHOP/génétique , Endoribonucleases/métabolisme , Endoribonucleases/génétique , Phosphorylation , Carcinome hépatocellulaire/métabolisme , Carcinome hépatocellulaire/anatomopathologie , Tumeurs du foie/métabolisme , Tumeurs du foie/anatomopathologie , Stress oxydatif/effets des médicaments et des substances chimiques , Séquestosome-1/métabolisme , Séquestosome-1/génétique , Transduction du signal/effets des médicaments et des substances chimiques , Protéines associées aux microtubules/métabolismeRÉSUMÉ
Secretion levels required of industrial Chinese hamster ovary (CHO) cell lines can challenge endoplasmic reticulum (ER) homeostasis, and ER stress caused by accumulation of misfolded proteins can be a bottleneck in biomanufacturing. The unfolded protein response (UPR) is initiated to restore homeostasis in response to ER stress, and optimization of the UPR can improve CHO cell production of therapeutic proteins. We compared the fed-batch growth, production characteristics, and transcriptomic response of an immunoglobulin G1 (IgG1) producer to its parental, non-producing host cell line. We conducted differential gene expression analysis using high throughput RNA sequencing (RNASeq) and quantitative polymerase chain reaction (qPCR) to study the ER stress response of each cell line during fed-batch culture. The UPR was activated in the IgG1 producer compared to the host cell line and our analysis of differential expression profiles indicated transient upregulation of ATF6α target mRNAs in the IgG1 producer, suggesting two upstream regulators of the ATF6 arm of the UPR, ATF6ß and WFS1, are rational engineering targets. Although both ATF6ß and WFS1 have been reported to negatively regulate ATF6α, this study shows knockdown of either target elicits different effects in an IgG1-producing CHO cell line. Stable knockdown of ATF6ß decreased cell growth without decreasing titer; however, knockdown of WFS1 decreased titer without affecting growth. Relative expression measured by qPCR indicated no direct relationship between ATF6ß and WFS1 expression, but upregulation of WFS1 in one pool was correlated with decreased growth and upregulation of ER chaperone mRNAs. While knockdown of WFS1 had negative impacts on UPR activation and product mRNA expression, knockdown of ATF6ß improved the UPR specifically later in fed-batch leading to increased overall productivity.
Sujet(s)
Facteur de transcription ATF-6 , Cricetulus , Immunoglobuline G , Réponse aux protéines mal repliées , Animaux , Cellules CHO , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Immunoglobuline G/génétique , Immunoglobuline G/métabolisme , Réponse aux protéines mal repliées/génétique , Stress du réticulum endoplasmique/génétique , Techniques de knock-down de gènes , Ingénierie cellulaire/méthodes , Techniques de culture cellulaire en batch/méthodes , Protéines membranaires/métabolisme , Protéines membranaires/génétiqueRÉSUMÉ
Previously, we found by constructing various luciferase reporters that a well-conserved ATF6-binding element in the CRELD2 promoter is activated by transient ATF6 overexpression. In this study, we established ATF6-deficient and ATF4-deficient cell lines to analyze CRELD2 mRNA and protein expression together with that of other ER stress-inducible factors. Our results showed that ATF6 deficiency markedly suppressed tunicamycin (Tm)-induced expression of unglycosylated CRELD2. This reduction reflected a decrease in the CRELD2 transcription level. On the other hand, a putative ATF4-binding site in the mouse CRELD2 promoter did not respond to Tm stimulation, but ATF4 loss resulted in reductions in CRELD2 mRNA and protein expression, accompanied by a decrease in Tm-induced ATF6 expression. In contrast, transient suppression of GADD34, an ATF4 downstream factor, suppressed Tm-induced CRELD2 protein expression without a decrease in ATF6 protein expression. Furthermore, we investigated the association of CRELD2 with a well-known ERAD substrate, namely, an α1-antitripsin truncation mutant, NHK, by generating various CRELD2 and NHK constructs. Coimmunoprecipitation of these proteins was observed only when the cysteine in the CXXC motif on the N-terminal side of CRELD2 was replaced with alanine, and the interaction between the two was found to be disulfide bond-independent. Taken together, these findings indicate that CRELD2 expression is regulated by multiple factors via transcriptional and posttranscriptional mechanisms. In addition, the N-terminal structure of CRELD2, including the CXXC motif, was suggested to play a role in the association of the target proteins. In the future, the identification and characterization of factors interacting with CRELD2 will be useful for understanding protein homeostasis under various ER stress conditions.
Sujet(s)
Molécules d'adhérence cellulaire , Stress du réticulum endoplasmique , Tunicamycine , Animaux , Humains , Souris , Facteur de transcription ATF-4/métabolisme , Facteur de transcription ATF-4/génétique , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Motifs d'acides aminés , Sites de fixation , Lignée cellulaire , Cellules HEK293 , Régions promotrices (génétique) , ARN messager/métabolisme , ARN messager/génétique , Tunicamycine/pharmacologie , Molécules d'adhérence cellulaire/métabolismeRÉSUMÉ
Hepatocellular carcinoma (HCC) presents a persistent challenge to conventional therapeutic approaches. SLC12A5 is implicated in an oncogenic capacity and facilitates the progression of cancer. The objective of this investigation is to scrutinize the inhibitory effects of borax on endoplasmic reticulum (ER)-stress and apoptosis mediated by SLC12A5 in HepG2 cells. Initially, we evaluated the cytotoxic impact of borax on both HL-7702 and HepG2 cell lines. Subsequently, the effects of borax on cellular morphology and the cell cycle of these lines were examined. Following this, we explored the impact of borax treatment on the mRNA and protein expression levels of SLC12A5, C/EBP homologous protein (CHOP), glucose-regulated protein-78 (GRP78), activating transcription factor-6 (ATF6), caspase-3 (CASP3), and cytochrome c (CYC) in these cellular populations. The determined IC50 value of borax for HL-7702 cells was 40.8 mM, whereas for HepG2 cells, this value was 22.6 mM. The concentrations of IC50 (22.6 mM) and IC75 (45.7 mM) of borax in HepG2 cells did not manifest morphological aberrations in HL-7702 cells. Conversely, these concentrations in HepG2 cells induced observable morphological and nuclear abnormalities, resulting in cell cycle arrest in the G1/G0 phase. Additionally, the levels of SLC12A5, ATF6, CHOP, GRP78, CASP3, and CYC were elevated in HepG2 cells in comparison to HL-7702 cells. Moreover, SLC12A5 levels decreased following borax treatment in HepG2 cells, whereas ATF6, CHOP, GRP78, CASP3, and CYC levels exhibited a significant increase. In conclusion, our data highlight the potential therapeutic effects of borax through the regulation of ER stress in HCC by targeting SLC12A5.
Sujet(s)
Apoptose , Borates , Carcinome hépatocellulaire , Survie cellulaire , Chaperonne BiP du réticulum endoplasmique , Stress du réticulum endoplasmique , , Tumeurs du foie , Humains , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Apoptose/effets des médicaments et des substances chimiques , Carcinome hépatocellulaire/métabolisme , Carcinome hépatocellulaire/anatomopathologie , Carcinome hépatocellulaire/génétique , Carcinome hépatocellulaire/traitement médicamenteux , Cycle cellulaire/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Protéines du choc thermique/métabolisme , Protéines du choc thermique/génétique , Cellules HepG2 , Tumeurs du foie/métabolisme , Tumeurs du foie/anatomopathologie , Tumeurs du foie/génétique , Tumeurs du foie/traitement médicamenteux , Facteur de transcription CHOP/métabolisme , Facteur de transcription CHOP/génétique , /effets des médicaments et des substances chimiques , /métabolisme , Borates/métabolisme , Borates/pharmacologieRÉSUMÉ
Currently, more than 55 million people around the world suffer from dementia, and Alzheimer's Disease and Related Dementias (ADRD) accounts for nearly 60-70% of all those cases. The spread of Alzheimer's Disease (AD) pathology and progressive neurodegeneration in the hippocampus and cerebral cortex is strongly correlated with cognitive decline in AD patients; however, the molecular underpinning of ADRD's causality is still unclear. Studies of postmortem AD brains and animal models of AD suggest that elevated endoplasmic reticulum (ER) stress may have a role in ADRD pathology through altered neurocellular homeostasis in brain regions associated with learning and memory. To study the ER stress-associated neurocellular response and its effects on neurocellular homeostasis and neurogenesis, we modeled an ER stress challenge using thapsigargin (TG), a specific inhibitor of sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), in the induced pluripotent stem cell (iPSC)-derived neural stem cells (NSCs) of two individuals from our Mexican American Family Study (MAFS). High-content screening and transcriptomic analysis of the control and ER stress-challenged NSCs showed that the NSCs' ER stress response resulted in a significant decline in NSC self-renewal and an increase in apoptosis and cellular oxidative stress. A total of 2300 genes were significantly (moderated t statistics FDR-corrected p-value ≤ 0.05 and fold change absolute ≥ 2.0) differentially expressed (DE). The pathway enrichment and gene network analysis of DE genes suggests that all three unfolded protein response (UPR) pathways, protein kinase RNA-like ER kinase (PERK), activating transcription factor-6 (ATF-6), and inositol-requiring enzyme-1 (IRE1), were significantly activated and cooperatively regulated the NSCs' transcriptional response to ER stress. Our results show that IRE1/X-box binding protein 1 (XBP1) mediated transcriptional regulation of the E2F transcription factor 1 (E2F1) gene, and its downstream targets have a dominant role in inducing G1/S-phase cell cycle arrest in ER stress-challenged NSCs. The ER stress-challenged NSCs also showed the activation of C/EBP homologous protein (CHOP)-mediated apoptosis and the dysregulation of synaptic plasticity and neurotransmitter homeostasis-associated genes. Overall, our results suggest that the ER stress-associated attenuation of NSC self-renewal, increased apoptosis, and dysregulated synaptic plasticity and neurotransmitter homeostasis plausibly play a role in the causation of ADRD.
Sujet(s)
Maladie d'Alzheimer , Stress du réticulum endoplasmique , Humains , Maladie d'Alzheimer/génétique , Maladie d'Alzheimer/métabolisme , Maladie d'Alzheimer/anatomopathologie , Cellules souches neurales/métabolisme , Cellules souches neurales/anatomopathologie , Protein-Serine-Threonine Kinases/génétique , Protein-Serine-Threonine Kinases/métabolisme , Endoribonucleases/génétique , Endoribonucleases/métabolisme , Cellules souches pluripotentes induites/métabolisme , Thapsigargine/pharmacologie , Démence/génétique , Démence/métabolisme , Démence/anatomopathologie , eIF-2 Kinase/génétique , eIF-2 Kinase/métabolisme , Mâle , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Neurogenèse , Protéine-1 liant la boite X/métabolisme , Protéine-1 liant la boite X/génétique , Femelle , Réponse aux protéines mal repliées , Facteur de transcription CHOPRÉSUMÉ
Exosomes generated from mesenchymal stem cells (MSCs) are thought to be a unique therapeutic strategy for several autoimmune deficiency illnesses. The purpose of this study was to elucidate the protective effects of human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-Exo) on CD4+ T cells dysfunction during graft-versus-host disease (GVHD) and to identify the underlying processes involved. Here, we showed that hUCMSC-Exo treatment can effectively attenuate GVHD injury by alleviating redox metabolism disorders and inflammatory cytokine bursts in CD4+ T cells. Furthermore, hUCMSC-Exo ameliorate ER stress and ATF6/CHOP signaling-mediated apoptosis in CD4+ T cells and promote the development of CD4+IL-10+ T cells during GVHD. Moreover, downregulating miR-16-5p in hUCMSC-Exo impaired their ability to prevent CD4+ T cells apoptosis and weakened their ability to promote the differentiation of CD4+IL-10+ T cells. Collectively, the obtained data suggested that hUCMSC-Exo suppress ATF6/CHOP signaling-mediated ER stress and apoptosis in CD4+ T cells, enhance the differentiation of CD4+IL-10+ T cells, and reverse the imbalance of immune homeostasis in the GVHD process by transferring miR-16-5p. Our study provided further evidence that GVHD patients can benefit from hUCMSC-Exo-mediated therapy.
Sujet(s)
Facteur de transcription ATF-6 , Lymphocytes T CD4+ , Stress du réticulum endoplasmique , Exosomes , Maladie du greffon contre l'hôte , Cellules souches mésenchymateuses , microARN , Transduction du signal , Facteur de transcription CHOP , microARN/métabolisme , microARN/génétique , Exosomes/métabolisme , Stress du réticulum endoplasmique/immunologie , Maladie du greffon contre l'hôte/immunologie , Maladie du greffon contre l'hôte/prévention et contrôle , Humains , Lymphocytes T CD4+/immunologie , Lymphocytes T CD4+/métabolisme , Animaux , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Cellules souches mésenchymateuses/métabolisme , Cellules souches mésenchymateuses/immunologie , Facteur de transcription CHOP/métabolisme , Facteur de transcription CHOP/génétique , Apoptose , Souris , Souris de lignée BALB C , Souris de lignée C57BL , Cordon ombilical/cytologie , Cellules cultivéesRÉSUMÉ
Lipid droplets (LDs) are dynamic organelles that store neutral lipids and are closely linked to obesity. Previous studies have suggested that Lycium barbarum polysaccharide (LBP) supplements can ameliorate obesity, but the underlying mechanisms remain unclear. In this study, we hypothesize that LBP alleviates LD accumulation in adipose tissue (AT) by inhibiting fat-specific protein 27 (Fsp27) through an activating transcription factor-6 (ATF6)/small-molecule sirtuin 1 (SIRT1)-dependent mechanism. LD accumulation in AT is induced in high-fat diet (HFD)-fed mice, and differentiation of 3T3-L1 preadipocytes (PAs) is induced. The ability of LBP to alleviate LD accumulation and the possible underlying mechanism are then investigated both in vivo and in vitro. The influences of LBP on the expressions of LD-associated genes ( ATF6 and Fsp27) are also detected. The results show that HFD and PA differentiation markedly increase LD accumulation in ATs and adipocytes, respectively, and these effects are markedly suppressed by LBP supplementation. Furthermore, LBP significantly activates SIRT1 and decreases ATF6 and Fsp27 expressions. Interestingly, the inhibitory effects of LBP are either abolished or exacerbated when ATF6 is overexpressed or silenced, respectively. Furthermore, SIRT1 level is transcriptionally regulated by LBP through opposite actions mediated by ATF6. Collectively, our findings suggest that LBP supplementation alleviates obesity by ameliorating LD accumulation, which might be partially mediated by an ATF6/SIRT1-dependent mechanism.
Sujet(s)
Cellules 3T3-L1 , Facteur de transcription ATF-6 , Tissu adipeux , Médicaments issus de plantes chinoises , Gouttelettes lipidiques , Souris de lignée C57BL , Sirtuine-1 , Animaux , Sirtuine-1/métabolisme , Sirtuine-1/génétique , Souris , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Tissu adipeux/métabolisme , Tissu adipeux/effets des médicaments et des substances chimiques , Gouttelettes lipidiques/métabolisme , Gouttelettes lipidiques/effets des médicaments et des substances chimiques , Mâle , Médicaments issus de plantes chinoises/pharmacologie , Alimentation riche en graisse/effets indésirables , Adipocytes/métabolisme , Adipocytes/effets des médicaments et des substances chimiques , Obésité/métabolisme , Obésité/traitement médicamenteux , Lycium/composition chimique , Différenciation cellulaire/effets des médicaments et des substances chimiques , Métabolisme lipidique/effets des médicaments et des substances chimiquesRÉSUMÉ
BACKGROUND: Intracerebral hemorrhage (ICH) comprises primary and secondary injuries, the latter of which induces increased inflammation and apoptosis and is more severe. Activating transcription factor 6 (ATF6) is a type-II transmembrane protein in the endoplasmic reticulum (ER). ATF6 target genes could improve ER homeostasis, which contributes to cryoprotection. Hence, we predict that ATF6 will have a protective effect on brain tissue after ICH. METHOD: The ICH rat model was generated through autologous blood injection into the right basal ganglia, the expression of ATF6 after ICH was determined by WB and IF. The expression of ATF6 was effectively controlled by means of intervention, and a series of measures was used to detect cell death, neuroinflammation, brain edema, blood-brain barrier and other indicators after ICH. Finally, the effects on long-term neural function of rats were measured by behavioral means. RESULT: ATF6 was significantly increased in the ICH-induced brain tissues. Further, ATF6 was found to modulate the expression of cystathionine γ-lyase (CTH) after ICH. Upregulation of ATF6 attenuated neuronal apoptosis and inflammation in ICH rats, along with mitigation of ICH-induced brain edema, blood-brain barrier deterioration, and cognitive behavior defects. Conversely, ATF6 genetic knockdown induced effects counter to those aforementioned. CONCLUSIONS: This study thereby emphasizes the crucial role of ATF6 in secondary brain injury in response to ICH, indicating that ATF6 upregulation may potentially ameliorate ICH-induced secondary brain injury. Consequently, ATF6 could serve as a promising therapeutic target to alleviate clinical ICH-induced secondary brain injuries.
Sujet(s)
Facteur de transcription ATF-6 , Hémorragie cérébrale , Cystathionine gamma-lyase , Animaux , Mâle , Rats , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Apoptose , Barrière hémato-encéphalique/métabolisme , Encéphale/métabolisme , Encéphale/anatomopathologie , Oedème cérébral/métabolisme , Lésions encéphaliques/métabolisme , Hémorragie cérébrale/métabolisme , Cystathionine gamma-lyase/métabolisme , Cystathionine gamma-lyase/génétique , Modèles animaux de maladie humaine , Rat Sprague-DawleyRÉSUMÉ
The inhibition of the unfolded protein response (UPR), which usually protects cancer cells from stress, may be exploited to potentiate the cytotoxic effect of drugs inducing ER stress. However, in this study, we found that ER stress and UPR activation by thapsigargin or tunicamycin promoted the lysosomal degradation of mutant (MUT) TP53 and that the inhibition of the UPR sensor ATF6, but not of ERN1/IRE1 or EIF2AK3/PERK, counteracted such an effect. ATF6 activation was indeed required to sustain the function of lysosomes, enabling the execution of chaperone-mediated autophagy (CMA) as well as of macroautophagy, processes involved in the degradation of MUT TP53 in stressed cancer cells. At the molecular level, by pharmacological and genetic approaches, we demonstrated that the inhibition of ATF6 correlated with the activation of MTOR and with TFEB and LAMP1 downregulation in thapsigargin-treated MUT TP53 carrying cells. We hypothesize that the rescue of MUT TP53 expression by ATF6 inhibition, could further activate MTOR and maintain lysosomal dysfunction, further inhibiting MUT TP53 degradation, in a vicious circle. The findings of this study suggest that the presence of MUT TP53, which often exerts oncogenic properties, should be considered before approaching treatments combining ER stressors with ATF6 inhibitors against cancer cells, while it could represent a promising strategy against cancer cells that harbor WT TP53.
Sujet(s)
Facteur de transcription ATF-6 , Stress du réticulum endoplasmique , Lysosomes , Sérine-thréonine kinases TOR , Thapsigargine , Protéine p53 suppresseur de tumeur , Réponse aux protéines mal repliées , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Lysosomes/métabolisme , Lysosomes/effets des médicaments et des substances chimiques , Humains , Protéine p53 suppresseur de tumeur/métabolisme , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Stress du réticulum endoplasmique/génétique , Thapsigargine/pharmacologie , Réponse aux protéines mal repliées/effets des médicaments et des substances chimiques , Réponse aux protéines mal repliées/génétique , Sérine-thréonine kinases TOR/métabolisme , Autophagie médiée par les chaperonnes/effets des médicaments et des substances chimiques , Autophagie médiée par les chaperonnes/génétique , Mutation/génétique , Lignée cellulaire tumorale , Autophagie/effets des médicaments et des substances chimiques , Autophagie/génétique , Facteurs de transcription à motifs basiques hélice-boucle-hélice et à glissière à leucines/métabolisme , Tumeurs/génétique , Tumeurs/anatomopathologie , Tumeurs/métabolisme , Tunicamycine/pharmacologie , Protéine de membrane-1 associée au lysosomeRÉSUMÉ
BACKGROUND: Oral squamous cell carcinoma (OSCC) is originating from oral mucosal epithelial cells. Autophagy plays a crucial role in cancer treatment by promoting cellular self-degradation and eliminating damaged components, thereby enhancing therapeutic efficacy. In this study, we aim to identify a novel autophagy-related biomarker to improve OSCC therapy. METHODS: We firstly utilized Cox and Lasso analyses to identify that ATF6 is associated with OSCC prognosis, and validated the results by Kaplan-Meier survival analysis. We further identified the downstream pathways and related genes by enrichment analysis and WGCNA analysis. Subsequently, we used short interfering RNA to investigate the effects of ATF6 knockdown on proliferation, migration, apoptosis, and autophagy in SCC-9 and SCC-15 cells through cell viability assay, transwell assay, EdU incorporation assay, flow cytometry analysis, western blot analysis and immunofluorescence analysis, etc. RESULTS: Bioinformatics analyses showed that ATF6 overexpression was associated with prognosis and detrimental to survival. In vitro studies verified that ATF6 knockdown reduced OSCC cell proliferation and migration. Mechanistically, ATF6 knockdown could promote cellular autophagy and apoptosis. CONCLUSION: We propose that ATF6 holds potential as a prognostic biomarker linked to autophagy in OSCC. This study provides valuable clues for further exploration of targeted therapy against OSCC.
Sujet(s)
Facteur de transcription ATF-6 , Autophagie , Marqueurs biologiques tumoraux , Carcinome épidermoïde , Mouvement cellulaire , Prolifération cellulaire , Régulation de l'expression des gènes tumoraux , Tumeurs de la bouche , Humains , Facteur de transcription ATF-6/génétique , Facteur de transcription ATF-6/métabolisme , Tumeurs de la bouche/génétique , Tumeurs de la bouche/anatomopathologie , Tumeurs de la bouche/métabolisme , Marqueurs biologiques tumoraux/génétique , Marqueurs biologiques tumoraux/métabolisme , Pronostic , Lignée cellulaire tumorale , Autophagie/génétique , Prolifération cellulaire/génétique , Mouvement cellulaire/génétique , Carcinome épidermoïde/génétique , Carcinome épidermoïde/métabolisme , Carcinome épidermoïde/anatomopathologie , Apoptose/génétique , Estimation de Kaplan-MeierRÉSUMÉ
BACKGROUND: Fluorouracil (5-FU) might produce serious cardiac toxic reactions. miRNA-199a-5p is a miRNA primarily expressed in myocardial cells and has a protective effect on vascular endothelium. Under hypoxia stress, the expression level of miRNA-199a-5p was significantly downregulated and is closely related to cardiovascular events such as coronary heart disease, heart failure, and hypertension. We explored whether 5-FU activates the endoplasmic reticulum stress ATF6 pathway by regulating the expression of miRNA-199a-5p in cardiac toxicity. METHODS: This project established a model of primary cardiomyocytes derived from neonatal rats and treated them with 5-FU in vitro. The expression of miRNA-199a-5p and its regulation were explored in vitro and in vivo. RESULTS: 5-FU decreases the expression of miRNA-199a-5p in cardiomyocytes, activates the endoplasmic reticulum stress ATF6 pathway, and increases the expression of GRP78 and ATF6, affecting the function of cardiomyocytes, and induces cardiac toxicity. The rescue assay further confirmed that miRNA-199a-5p supplementation can reduce the cardiotoxicity caused by 5-FU, and its protective effect on cardiomyocytes depends on the downregulation of the endoplasmic reticulum ATF6 signaling pathway. CONCLUSIONS: 5-FU can down-regulate expression of miRNA-199a-5p, then activate the endoplasmic reticulum stress ATF6 pathway, increase the expression of GRP78 and ATF6, affect the function of cardiomyocytes, and induce cardiac toxicity.
Sujet(s)
Facteur de transcription ATF-6 , Cardiotoxicité , Régulation négative , Chaperonne BiP du réticulum endoplasmique , Stress du réticulum endoplasmique , Fluorouracil , microARN , Myocytes cardiaques , Transduction du signal , Animaux , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , microARN/métabolisme , microARN/génétique , Rats , Myocytes cardiaques/effets des médicaments et des substances chimiques , Myocytes cardiaques/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Régulation négative/effets des médicaments et des substances chimiques , Fluorouracil/toxicité , Fluorouracil/effets indésirables , Cardiotoxicité/métabolisme , Cardiotoxicité/génétique , Cardiotoxicité/étiologie , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Cellules cultivées , Rat Sprague-Dawley , MâleRÉSUMÉ
Pulmonary hypertension (PH) is a severe clinical syndrome with pulmonary vascular remodeling and poor long-term prognosis. Neurotensin receptor 1 (Ntsr1), serve as one of the G protein-coupled receptors (GPCRs), implicates in various biological processes, but the potential effects of Ntsr1 in PH development are unclear. The Sugen/Hypoxia (SuHx) or monocrotaline (MCT) induced rat PH model was used in our study and the PH rats showed aggravated pulmonary artery remodeling and increased right ventricular systolic pressure (RVSP). Our results revealed that Ntsr1 induced endoplasmic reticulum (ER) stress response via ATF6 activation contributed to the development of PH. Moreover, RNA-sequencing (RNA-seq) and phosphoproteomics were performed and the Ntsr1-JAK2-STAT3-thrombospondin 1 (Thbs1)-ATF6 signaling was distinguished as the key pathway. In vitro, pulmonary artery smooth muscle cells (PASMCs) under hypoxia condition showed enhanced proliferation and migration properties, which could be inhibited by Ntsr1 knockdown, JAK2 inhibitor (Fedratinib) treatment, STAT3 inhibitior (Stattic) treatment, Thbs1 knockdown or ATF6 knockdown. In addition, adeno-associated virus 1 (AAV1) were used to knockdown the expression of Ntsr1, Thbs1 or ATF6 in rats and reversed the phenotype of PH. In summary, our results reveal that Ntsr1-JAK2-STAT3-Thbs1 pathway can induce enhanced ER stress via ATF6 activation and increased PASMC proliferation and migration capacities, which can be mechanism of the pulmonary artery remodeling and PH. Targeting Ntsr1 might be a novel therapeutic strategy to ameliorate PH.
Sujet(s)
Stress du réticulum endoplasmique , Hypertension pulmonaire , Kinase Janus-2 , Récepteur neurotensine , Facteur de transcription STAT-3 , Transduction du signal , Animaux , Mâle , Rats , Facteur de transcription ATF-6/métabolisme , Facteur de transcription ATF-6/génétique , Mouvement cellulaire , Prolifération cellulaire , Stress du réticulum endoplasmique/génétique , Hypertension pulmonaire/métabolisme , Hypertension pulmonaire/anatomopathologie , Kinase Janus-2/métabolisme , Myocytes du muscle lisse/métabolisme , Myocytes du muscle lisse/anatomopathologie , Artère pulmonaire/métabolisme , Artère pulmonaire/anatomopathologie , Rat Sprague-Dawley , Facteur de transcription STAT-3/métabolisme , Remodelage vasculaire , Récepteur neurotensine/métabolisme , Thrombospondine-1/métabolismeRÉSUMÉ
BACKGROUND: ATF6-associated Achromatopsia (ACHM) is a rare autosomal recessive disorder characterized by reduction of visual acuity, photophobia, nystagmus, and poor color vision. METHODS: Detailed ophthalmological examinations were performed in a Chinese patient with ACHM. Whole exome sequencing and Sanger sequencing were performed to detect the disease-causing gene in the patient. RESULTS: A 6-year-old girl presented photophobia, low vision and reduced color discrimination. Small yellow lesion in the macula of both eyes was observed. FAF demonstrated hypofluorescence in the macular fovea. OCT images revealed interruption of ellipsoid and interdigitation zone in the foveal area and a loss of the foveal pit. ERG showed relatively normal rod responses and unrecordable cone responses. Sequencing result identified a novel splicing variant c.354 + 6T>C in the ATF6 gene (NM_007348.4). CONCLUSIONS: We reported detailed clinical features and genetic analysis of a new Chinese ATF6-associated patient with ACHM.
Sujet(s)
Troubles de la vision des couleurs , Enfant , Femelle , Humains , Facteur de transcription ATF-6/génétique , Chine , Troubles de la vision des couleurs/diagnostic , Photophobie/diagnostic , Photophobie/anatomopathologie , Cellules photoréceptrices en cône de la rétine/anatomopathologie , Tomographie par cohérence optique/méthodesRÉSUMÉ
Mammalian cells have three types of endoplasmic reticulum (ER) stress-sensing molecules: ATF6, IRE1, and PERK. Among these, ATF6 is unique in that it is processed in an ER-stress-specific manner and functions as a transcription factor for the activation of anti-ER stress genes (such as BiP). ATF6 is known to have two homologues, ATF6α and ATF6ß, and a greater understanding of their functions has been achieved through analyses using cultured cells. Physiological functions are also gradually being investigated in mice lacking ATF6α or ATF6ß. However, little is known about the effects on mouse organisms of the deletion of both the ATF6α and ATF6ß genes, since such double-knockout (DKO) mice suffer embryonic lethality at an early developmental stage. In this study, we generated and analyzed ATF6 DKO mice in which embryonic lethality was evaded by using Cre/loxP technology. Pancreatic ß cell-specific ATF6 DKO mice were born normally and lived without dysregulation of blood-glucose levels but had a reduced tolerance to glucose. Islets isolated from ATF6 DKO mice also showed low production and secretion of insulin and mild enhancement of IRE1 and PERK activity. We further examined the developmental abnormalities of systemic ATF6 DKO mice. The phenotypes of ATF6α-/-; ATF6ß-/- mice were similar to those previously reported, but ATF6α+/-; ATF6ß-/- and ATF6α-/-; ATF6ß+/- mice showed embryonic lethality at middle developmental stages, unlike those reported. Analysis of embryonic fibroblasts derived from these mice revealed that ATF6α and ATF6ß have a gene-dose-dependent functional redundancy and display distinct differences in their ability to induce BiP expression. (250 words).